AbCellera Biologics (NasdaqGS:ABCL) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Company ParticipantsCarl Hansen - CEONone - Company RepresentativeMalcolm Hoffman - Senior BioPharma Equity Research AssociateAndrew Booth - CFONone - Company RepresentativeTryn Stimart - Chief Legal and Compliance OfficerConference Call ParticipantsSteven Dechert - AnalystFaisal Khurshid - Senior Research AnalystAndrea Newkirk - AnalystOperatorGood afternoon, and welcome to AbCellera's Third Quarter 2025 Business Update ...